Panakeia

London, United Kingdom Founded: 2018 • Age: 8 yrs Minicorn
AI-based software is provided for cancer diagnosis and precision treatment.

About Panakeia

Panakeia is a company based in London (United Kingdom) founded in 2018. Panakeia has raised $3.79 million across 2 funding rounds. The company has 12 employees. Panakeia offers products and services including PANProfiler Colon and Multi-Omics Analysis. Panakeia operates in a competitive market with competitors including Asimov, Cellarity, Metaphore, Boston Medical Sciences and Evolved By Nature, among others.

  • Headquarter London, United Kingdom
  • Employees 12
  • Stage Minicorn
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Website panakeia.ai
  • Social LinkedIn X
  • Legal Name Panakeia Technologies Limited
  • Date of Incorporation 26 Nov, 2018
  • Jurisdiction CAMBRIDGE, ENGLAND
Key Metrics
  • Total Equity Funding
    $3.79M (USD)

    in 2 rounds

  • Latest Funding Round
    $3.73M (USD), Seed

    Sep 2019

  • Employee Count
    12

Products & Services of Panakeia

Panakeia offers a comprehensive portfolio of products and services, including PANProfiler Colon and Multi-Omics Analysis.

PANProfiler Colon
AI-driven Tool

AI tool for molecular profiling in colon cancer diagnostics

Multi-Omics Analysis
Diagnostic Platform

Platform for comprehensive molecular analysis from tissue images

Funding Insights of Panakeia

Panakeia has successfully raised a total of $3.79M across 2 strategic funding rounds. The most recent funding activity was a Seed round of $3.73 million completed in September 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $3.79M
  • Total Rounds 2
  • Last Round Seed β€” $3.73M
  • First Round $51,290

    (Nov 2018)

All 2 funding rounds of Panakeia with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Sep 2019$3.73MSeed$10.73M–
–
Nov 2018$51,290Seed$2.09M–
–
Valuation history
DateValuationStage
Sep 2019$10.73Mβ€’β€’β€’β€’β€’β€’β€’β€’
Nov 2018$2.09Mβ€’β€’β€’β€’β€’β€’β€’β€’

Last known valuation $10.73M (Sep 2019).

People of Panakeia

5 people are tracked at Panakeia (2 in leadership, 3 in team); the tracked headcount is 12.

NameRoleGroup
Hasan Djenan
Commercial Director Of Clinical SalesLeadership
Pahini Pandya
Founder & CEOLeadership
Salim Arslan
Machine Learning LeadTeam
Cher Bass (Ph.D)
Machine Learning ScientistTeam
Foivos Ntelemis
Machine Learning EngineerTeam
Premium access

Complete people profiles for Panakeia

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of Panakeia

4 dated milestones of Panakeia across 1 years, from founding to its latest funding, stage changes and deals.

  1. Founded Panakeia is founded.
  2. Funding First funding round of $51K.
  3. Milestone Reaches Minicorn status.
  4. Funding Latest funding round, Seed, of $3.7M.

Competitors of Panakeia

Panakeia operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Asimov, Cellarity, Metaphore, Boston Medical Sciences and Evolved By Nature, among others.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
asimov.com2017Boston, United States$209.4M87
Provider of integrated suite for advanced genetic design and manufacturing
cellarity.com2015Cambridge, United States$294M117
Developer of drugs to treat various diseases
metaphorebio.com2021Cambridge, United States$50M–
Provider of machine language and computational platform for drug discovery
b-ms.tech2023Chuo-ku, Japan$8.79M–
AI-powered colorectal cancer screening system
evolvedbynature.com2013Medford, United States$190M99
Digital technology for biomedicinal molecule development in research is utilized.
algorithmicbiologics.com2021Bengaluru, India$2.84M–
Provider of software solutions for molecular diagnostics and discovery
nevia.bio2023Haifa, Israel$3.1M–
Machine learning-enabled platform for early detection of women-related diseases
lizard.bio2018Ghent, Belgium–22
Software solutions for bioinformatics data processing and integration are provided.
Premium access

Detailed competitors of Panakeia

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of Panakeia

The website of Panakeia (panakeia.ai) receives about 1.1K visits a month.

  • Monthly visits
    1.1K

    ▼ 45.5% vs previous month

Latest news on Panakeia

Premium access

Complete news archive for Panakeia

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Similar companies to Panakeia

10 companies that operate in the same segment as Panakeia (Clinical IT & Data Platforms), ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Provider of fitness memberships encompassing group classes, gyms, and at-home workouts
2016Bengaluru, Karnataka, IndiaUSD 713.57 M––
Employee health benefits are facilitated via a cloud-based platform.
2007Plymouth Meeting, Pennsylvania, United StatesUSD 228.3 M––
Healthcare appointments are booked online via Zocdoc's platform.
2007New York, New York, United StatesUSD 425.97 MUSD 4.66 M233
Virtual physical therapy and digital pain care solutions are provided.
2015San Francisco, California, United StatesUSD 854.44 M––
Tech-enabled mental health solutions for employers are provided.
2016New York, New York, United StatesUSD 508.73 M––
App-based health insurance is offered to individuals and businesses.
2016Paris, FranceUSD 863.12 M––
Virtual care programs for managing chronic diseases are provided.
2011San Francisco, California, United StatesUSD 450.12 MUSD 260.21 M–
AI-driven EMR and practice management software is delivered for clinics.
2010Boca Raton, Florida, United StatesUSD 329.17 M––
Cloud-based administrative tools for healthcare providers are offered.
1997Watertown, United StatesUSD 40 M––
Membership-based primary care platform is offered for employees and consumers.
2007San Francisco, California, United StatesUSD 402.56 M––
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Panakeia

Panakeia was founded in 2018.

Panakeia is headquartered in London, United Kingdom. It is registered at London, England, United Kingdom.

Panakeia is a funded company, having raised a total of $3.79M across 2 funding rounds to date. The company's 1st funding round was a Seed of $51.29K, raised on Nov 2018.

Panakeia has 12 employees.

Panakeia was founded in 2018 in London, United Kingdom, as a provider of AI-based software focused on diagnosis and precision treatment for cancer prevention. Expertise is applied in biomarker discovery and validation, tissue phenomics, therapeutics, drug design, bioinformatics, and machine learning. Operations center on developing technologies for single-step diagnostics and targeted therapies within the healthcare sector.

Panakeia's top competitors include Asimov, Cellarity and Boston Medical Sciences.

Panakeia offers PANProfiler Colon and Multi-Omics Analysis.

The valuation of Panakeia is $10.73M as of Sep 2019.

Panakeia operates through Panakeia Technologies Limited.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available